The biological tests conducted on the pure drug and its PU nanoformulations, respectively, revealed a significant antiproliferative activity on the ER+/− breast cancer cell lines exhibited by pure ABZ which increased as a result of entrapment into the PU nanoparticles. The gene discussed is ESR1; the disease is breast carcinoma.